Vigorous HIV-1-Specific CD4 ⁺ T Cell Responses Associated with Control of Viremia

TLDR

Virus‑specific CD4⁺ T helper lymphocytes are essential for effective immunity in chronic viral infections but are typically undetectable in chronic HIV‑1 infection. The study investigates whether HIV‑1–specific helper CD4⁺ T cells contribute to viral control and could be leveraged for immunotherapy and vaccine development. Individuals who naturally suppress HIV‑1 viremia without therapy display vigorous, persistent CD4⁺ T cell proliferation that produces interferon‑γ and antiviral β‑chemokines; in chronic infection these proliferative responses inversely correlate with viral load, and they are also induced by potent antiviral therapy in acutely infected persons.

Abstract

Virus-specific CD4 + T helper lymphocytes are critical to the maintenance of effective immunity in a number of chronic viral infections, but are characteristically undetectable in chronic human immunodeficiency virus–type 1 (HIV-1) infection. In individuals who control viremia in the absence of antiviral therapy, polyclonal, persistent, and vigorous HIV-1–specific CD4 + T cell proliferative responses were present, resulting in the elaboration of interferon-γ and antiviral β chemokines. In persons with chronic infection, HIV-1–specific proliferative responses to p24 were inversely related to viral load. Strong HIV-1–specific proliferative responses were also detected following treatment of acutely infected persons with potent antiviral therapy. The HIV-1–specific helper cells are likely to be important in immunotherapeutic interventions and vaccine development.